Nanjing Suzhong Pharmacy Research

Nanjing Suzhong Pharmaceutical Research is the dedicated research and development subsidiary of the Suzhong Pharmaceutical Group, located in the pharmaceutical hub of Nanjing, China. The company focuses on the modernization of Traditional Chinese Medicine (TCM) and the discovery of innovative small molecule drugs, particularly for chronic and age-related diseases. Its primary therapeutic focus areas include nephrology, cardiology, and cerebrovascular health, supporting a portfolio that includes the widely recognized Huangkui Capsule. The research center integrates advanced chemical synthesis, formulation development, and pharmacological testing to bridge traditional therapeutic wisdom with modern evidence-based medicine. By collaborating with leading academic institutions, the company maintains a robust pipeline of both improved traditional formulations and novel chemical entities.